Source link : https://www.newshealth.biz/health-news/gene-editing-therapy-shows-promise-in-hereditary-angioedema/
A single dose of the CRISPR-based gene-editing therapy NTLA-2002 significantly reduced angioedema attacks compared with placebo in patients with hereditary angioedema, according to results from a phase II randomized study presented at the recent American College of Allergy, Asthma & Immunology (ACAAI) annual meeting. In this exclusive MedPage Today video, study author Danny M. Cohn, […]
Author : News Health
Publish date : 2024-11-18 19:06:41
Copyright for syndicated content belongs to the linked Source.